A conversation with scientists and industry experts from both sides of the Atlantic organized by the German Consulates of Boston and San Francisco as well as GABA California and GABC Boston.
- Johannes Ahrendts, Head of strategy, GAVI, the Vaccine Alliance
- Antony Blanc, Chief Business and Chief Commercial Officer, CureVac AG
- Andrew Bulpin, Executive Vice President Process Solutions, MilliporeSigma
- Melanie Ott, Director, Gladstone Institute of Virology, Professor, Department of Medicine, UCSF
Jan Hartmann, Vice President, Head of Medical Affairs, Clinical Development & Medical Safety, Haemonetics